Dr. Wei Zhang 张伟
Chief Physician, Associate Professor
Department of Hepatobiliary Oncology, Tianjin Medical University Cancer Institute & Hospital, Tianjin
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Open and laparoscopic surgery for benign and malignant tumors of the liver, bile ducts, gallbladder, and pancreas. Expertise includes complex resections and comprehensive treatment for primary liver cancer, cholangiocarcinoma, gallbladder cancer, pancreatic cancer, and colorectal liver metastases.
Dr. Zhang holds a PhD in Surgery from Fudan University and completed postdoctoral training at the University of Tokyo Hospital. A Chief Physician and Associate Professor at Tianjin Medical University Cancer Institute & Hospital, Dr. Zhang has performed over 3,000 hepatobiliary and pancreatic surgeries, with an 80% minimally invasive rate. Dr. Zhang supervises graduate students, leads two National Natural Science Foundation projects, and serves on editorial boards for multiple journals.
Professional roles
- Member, Chinese Medical Association
- Member, Liver Cancer Professional Committee, China Anti-Cancer Association
- Vice Chair, Youth Committee on Liver Cancer, China Anti-Cancer Association
- Young Council Member, Chinese Society of Clinical Oncology (CSCO)
Name order: in Chinese the family name comes first (Zhang Wei). Papers usually list the name as Wei Zhang or Zhang W.
Selected publications
190 papers on PubMed matched by name and affiliation; 31 as first or senior author since 2016. Most recent first- or senior-author papers:
- Asia Pac J Oncol Nurs, 2026 (first author): Self-management of reflux symptoms after esophagectomy in China: A qualitative study. PubMed 41847239
- Front Oncol, 2026 (senior author): Chemotherapy combined with immunotherapy vs. chemotherapy: comparison of safety and efficacy in adjuvant therapy for intrahepatic cholangiocarcinoma. PubMed 42440482
- Surg Oncol, 2026 (senior author): Laparoscopic right caudate lobectomy combined with right posterior lobectomy for hepatocellular carcinoma after neoadjuvant therapy (with video). PubMed 41980503
- Surg Endosc, 2026 (senior author): Laparoscopic vs. open liver resection for malignancies involving segment 7: short-term outcomes and learning curve analysis using propensity score matching. PubMed 41184676
- Medicine (Baltimore), 2025 (senior author): Presence of symptoms predicts poor survival and correlates with COX-2 expression in resected intrahepatic cholangiocarcinoma patients. PubMed 41431078
- Anticancer Drugs, 2025 (senior author): Inhibition of nuclear receptor coactivator 5 overcomes acquired lenvatinib resistance driven by protein kinase B-mammalian target of rapamycin signaling in hepatocellular carcinoma. PubMed 40747694
- EClinicalMedicine, 2025 (senior author): Donafenib and sintilimab combined with hepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma: a prospective, single-arm phase II trial (DoHAICs study). PubMed 40475000
- Cancer Biol Med, 2024 (senior author): Personalized laparoscopic radical resection of gallbladder cancer by staining of the liver draining area through ICG injection into the cholecystic artery. PubMed 39475217
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that most papers list this doctor's hospital and department.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion